RAAPID INC is a technology company.
RAAPID INC has raised $7.0M across 1 funding round.
RAAPID INC has raised $7.0M in total across 1 funding round.
RAAPID INC has raised $7.0M in total across 1 funding round.
RAAPID INC's investors include Cervin Ventures, Crosslink Capital, M12, Thomvest Ventures.
RAAPID INC is a healthcare technology company specializing in neuro-symbolic artificial intelligence solutions that enhance risk adjustment and clinical decision support. Their autonomous AI platform processes both structured and unstructured patient data to improve accuracy in risk adjustment coding, chart review, and clinical decision-making, primarily serving health plans, providers, and medical coding companies. RAAPID’s technology significantly reduces project timelines and costs while improving coding accuracy and productivity, supporting value-based care initiatives with integrated EHR solutions and scalable AI-as-a-Service offerings[1][2][4].
Founded in 2022 and headquartered in Louisville, Kentucky, RAAPID’s roots trace back to 2004 when its founders, Chetan Parikh and Vatsal Ghiya—engineering students and roommates at the University of Massachusetts—started a medical transcription company. Over the years, they evolved their focus from transcription to clinical natural language processing (NLP) and revenue cycle management platforms, launching computer-assisted coding (CAC) and clinical documentation improvement (CDI) solutions by 2015. The idea for RAAPID’s advanced AI platform emerged from ongoing innovation in clinical NLP and risk adjustment workflows, culminating in the 2022 launch of their neuro-symbolic AI-powered risk adjustment platform designed to transform value-based care[3].
RAAPID rides the growing trend of AI-driven automation in healthcare, particularly in risk adjustment and value-based care, where accurate patient risk stratification and coding directly impact reimbursement and care quality. The timing is critical as healthcare payers and providers face increasing pressure to optimize costs while improving outcomes. RAAPID’s platform addresses the healthcare trilemma of balancing speed, accuracy, and cost, leveraging advances in neuro-symbolic AI to deliver a quantum leap in risk adjustment technology. By improving coding accuracy and operational efficiency, RAAPID influences the broader healthcare ecosystem by enabling better resource allocation, reducing administrative burden, and supporting data-driven clinical decisions[1][2][5].
Looking ahead, RAAPID is positioned to expand its impact by deepening integration with electronic health records and scaling its AI-as-a-Service model to more healthcare organizations. Trends such as increased adoption of value-based care models, regulatory emphasis on accurate risk adjustment, and advances in AI explainability will shape RAAPID’s journey. Their continued innovation in neuro-symbolic AI and clinical NLP will likely strengthen their leadership in healthcare AI, potentially broadening applications beyond risk adjustment into other clinical decision support areas. RAAPID’s trajectory suggests a growing influence on how healthcare systems leverage AI to optimize care delivery and reimbursement accuracy, fulfilling their mission to revolutionize risk adjustment with breakthrough speed, accuracy, and value[2][4].
RAAPID INC has raised $7.0M across 1 funding round. Most recently, it raised $7.0M Series A in January 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2025 | $7.0M Series A | Cervin Ventures, Crosslink Capital, M12, Thomvest Ventures |